QIAstat-Dx呼吸道面板V2多中心评估:与ePlex RPP的回顾性比较
该研究为首次多中心回顾性比较,用287例疑似呼吸道感染样本评估QIAstat-Dx呼吸道面板V2与ePlex RPP的表现。QIAstat-Dx检出ePlex所检338个靶标中的312个(92%),差异多见于低病原载量样本,另检出19个额外靶标,其中9个经第三种方法确认为真阳性。QIAstat-Dx可生成循环阈值(CT)值,整体表现良好。
要点
- QIAstat-Dx RP对ePlex RPP检出靶标的符合率为92%(312/338)。
- 差异结果多出现在低病原载量样本中。
- QIAstat-Dx可提供CT值,有助于结果解读。
核心结论
- QIAstat-Dx RP与ePlex RPP相比对呼吸道病原体检出表现良好,可作为快速准确的样本进-结果出多重检测面板。
研究设计与样本
- 多中心回顾性比较研究,使用287例疑似呼吸道感染患者的呼吸道样本,比较QIAstat-Dx RP与ePlex RPP的检测性能。
主要发现
- QIAstat-Dx RP检出ePlex RPP所检338个呼吸道靶标中的312个(92%)。
- 多数差异结果见于低病原载量样本。
- QIAstat-Dx RP在19份样本中额外检出19个靶标,其中9个经第三种方法确认为真阳性。
关键数值与推荐
- QIAstat-Dx RP可同时快速(约70分钟)检测18种病毒和3种细菌呼吸道病原体。
- QIAstat-Dx RP检出ePlex RPP所检靶标的92%(312/338)。
- QIAstat-Dx系统可生成循环阈值(CT)值。
临床怎么用
- QIAstat-Dx RP可用于常见病毒和细菌呼吸道病原体的快速多重检测,有望指导适当治疗和感染控制措施。
局限性
- 本研究为回顾性比较,差异结果多出现在低病原载量样本中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
QIAstat-Dx Respiratory Panel V2 (RP) is a novel molecular-method-based syndromic test for the simultaneous and rapid (∼70-min) detection of 18 viral and 3 bacterial pathogens causing respiratory infections. This report describes the first multicenter retrospective comparison of the performance of the QIAstat-Dx RP assay to the established ePlex Respiratory Pathogen Panel (RPP) assay, for which we used 287 respiratory samples from patients suspected with respiratory infections. The QIAstat-Dx RP assay detected 312 (92%) of the 338 respiratory targets that were detected by the ePlex RPP assay. Most of the discrepant results have been observed in the low-pathogen-load samples. In addition, the QIAstat-Dx RP assay detected 19 additional targets in 19 respiratory samples that were not detected by the ePlex RPP assay. Nine of these discordant targets were considered to represent true positives after discrepancy testing by a third method. The main advantage of the QIAstat-Dx system compared to other syndromic testing systems, including the ePlex RPP assay, is the ability to generate cycle threshold (CT ) values, which could help with the interpretation of results. Taking the data together, this study showed good performance of the QIAstat-Dx RP assay in comparison to the ePlex RPP assay for the detection of respiratory pathogens. The QIAstat-Dx RP assay offers a new, rapid, and accurate sample-to-answer multiplex panel for the detection of the most common viral and bacterial respiratory pathogens and therefore has the potential to direct appropriate therapy and infection control precautions.
引用
- Boers SA, Melchers WJG, Peters CJA, et al. Multicenter Evaluation of QIAstat-Dx Respiratory Panel V2 for Detection of Viral and Bacterial Respiratory Pathogens. J Clin Microbiol. 2020. PMID: 32229601. doi:10.1128/JCM.01793-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。